Obesity Today—November 11, 2025
November 11, 2025BioPharma and Tech News,Novo NordiskTirzepatide,Eli Lilly,type 2 diabetes,GLP-1 receptor agonist,Obesity News,Metabolic syndrome,MC4R agonist
Track this week’s obesity headlines: Obesity Week 2025 highlights, industry…
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery
November 11, 2025Oncology,clinical trials,market access,AI in healthcare,HER2,biopharma,Lucid Diligence Brief,payer access,diligence,venture fundingpartnerships
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional…
Oncology Video Recap—November 10, 2025
November 10, 2025head and neck squamous cell carcinoma,Trodelvy,abbvie,astrazeneca,merck,BioPharma and Tech News,Gilead,Keytruda,ENHERTU,Akeso,Daiichi Sankyo,Cellectar,Oncology News,Non-muscle invasive bladder cancerA2 Biotherapeutics,Relmada Therapeutics
This biweekly edition spotlights the most important trends driving the future…
Hematology Today—November 10, 2025
November 10, 2025Cell Therapy,Multiple Myeloma,Sickle Cell Disease,Moderna,BioPharma and Tech News,antibody drug conjugate,Beta Thalassemia,Orphan Drug Designation,Acute Myeloid Leukemia,Hematology NewsT-cell engager,Regeneron Pharmaceuticals
This week’s Hematology update spotlights fresh breakthroughs, regulatory…
Oncology Today—November 10, 2025
November 10, 2025merck,BioPharma and Tech News,antibody drug conjugate,Gilead Sciences,Oncology News,Non-small cell lung cancer,CAR T cell therapy,Triple-negative breast cancer,Non-muscle invasive bladder cancermRNA therapeutics,IL-2 pathway
This week’s Oncology update spotlights key developments, regulatory milestones,…
AI in Healthcare and Digital Health Today—November 10, 2025
November 10, 2025OpenEvidence,manifold bio,cancer,evinova,roche,noom,Insilico Medicine,american college of cardiology,BioPharma and Tech News,obesity,diabetes,Eli Lilly,Omada health,Cardiovascular Disease,Evaxion,AI in Healthcare and Digital Health,inflammatory bowel diseasecardiosense,flatiron health
This week’s AI in Healthcare and Digital Health brief distills AI-driven…
Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic diseases
November 10, 2025clinical development,biopharma,Lucid Diligence Brief,payer access,metabolic disease,diligence,RNAi,delivery technology,partneringGLP-1 landscape
Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic…
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding
November 9, 2025Oncology,clinical trials,Regulatory,AI in healthcare,immunology,biopharma,Lucid Diligence Brief,payer access,diligence,partnershipsde novo proteins
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding Professional audiences…
Lucid Diligence Brief: Lumonus A$25M Series B
November 8, 2025digital health,reimbursement,Regulatory,AI in healthcare,biopharma,Lucid Diligence Brief,payer access,diligence,oncology operations,clinical workflowsradiation oncology
Lucid Diligence Brief: Lumonus A$25M Series B Professional audiences only. Not…
AHA 2025 Preview: Key Cardiovascular Highlights to Watch
November 7, 2025cardiovascular science,arrhythmias,Our Insights,lipids,AI,atherosclerosis,machine learning,CAD,obesity,prevention,HEART FAILURE,diabetes,Atrial fibrillation,hypertension,stroke,American Heart Association,PAD,Structural heart diseaseConference Previews,AHA 2025
AHA 2025 at a glance Get ready for AHA 2025 with LucidQuest’s concise preview.…
Respiratory Today—November 7, 2025
November 7, 2025COPD,BioPharma and Tech News,INOVIO,Idiopathic Pulmonary Fibrosis,Endeavor BioMedicines,Respiratory News,Recurrent respiratory papillomatosis,Tobramycin,TaladegibRitedose,Epithelial biology
This week’s respiratory update spotlights key developments, regulatory…
Vaccines Today—November 7, 2025
November 7, 2025takeda,BioPharma and Tech News,Dengue Vaccine,COVID-19 vaccine,Valneva,GC Biopharma,Vaccine news,Zika vaccine,Paratyphoid vaccine,Anthrax vaccineNeoantigen vaccine,Mucosal immunity
Get up to speed with this week’s Vaccine Research news, featuring clinical…









